Murayama T, Oda H, Nomura Y
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
J Cell Physiol. 1996 Dec;169(3):448-54. doi: 10.1002/(SICI)1097-4652(199612)169:3<448::AID-JCP5>3.0.CO;2-O.
Recent studies have shown that mastoparan, an amphiphilic peptide derived from wasp venom, modifies the secretion of neurotransmitters and hormones from a variety of cell types. Mastoparan interacts with heterotrimeric guanine nucleotide-binding proteins (G proteins) such as Gi and G(o), which are ADP-ribosylated by pertussis toxin (PTX) and thereby uncoupled from receptors. Previously, some of the effects of mastoparan including secretion were reported to be modified selectively by PTX but not by cholera toxin (CTX). In the present study, we examined the influence of bacterial toxins on the effects of mastoparan in PC12 cells. Mastoparan stimulated [3H]noradrenaline (NA) release from prelabeled PC12 cells in the absence of CaCl2, although high K+ or ATP-stimulated the release in a Ca(2+)-dependent manner. Pretreatment with CTX, not PTX, for 24 h inhibited mastoparan-stimulated [3H]NA release. Mastoparan inhibited forskolin-stimulated cyclic AMP accumulation in a dose-dependent manner, although mastoparan had no effect by itself. Pretreatment with PTX completely abolished the inhibitory effect of carbachol via Gi on cyclic AMP accumulation and partially reduced the effect of mastoparan. However, the inhibitory effect of 20 microM mastoparan was not modified by pretreatment with PTX. Thus, we investigated the effect of mastoparan on CTX-catalyzed [32P]ADP-ribosylation of proteins in PC12 cells. A subunit of CTX (CTX-A) catalyzed [32P]ADP-ribosylation of many proteins in the cytosolic fraction of PC12 cells. One of these was a 20 kDa protein, named ADP-ribosylating factor (ARF). The addition of mastoparan to assay mixtures inhibited ADP-ribosylation of many proteins including ARF and CTX-A in the presence of the cytosolic fraction. In the absence of the cytosolic fraction, however, mastoparan slightly enhanced ADP-ribosylation of bovine serum albumin and auto-ADP-ribosylation by CTX-A. Mastoparan did not inhibit ADP-ribosylation of the alpha subunit of Gs in the membrane fraction. These findings suggest that 1) mastoparan interacts with PTX-insensitive and CTX-sensitive factor(s) to stimulate NA release, and 2) mastoparan interacts with ARF inhibiting its activity to enhance the ADP-ribosylation reaction by CTX. ARF may be an exocytosis-linked G protein.
最近的研究表明,蜂毒明肽这种源自黄蜂毒液的两亲性肽,可改变多种细胞类型中神经递质和激素的分泌。蜂毒明肽与异三聚体鸟嘌呤核苷酸结合蛋白(G蛋白)如Gi和G(o)相互作用,这些蛋白会被百日咳毒素(PTX)进行ADP核糖基化,从而与受体解偶联。此前,据报道蜂毒明肽的一些作用(包括分泌作用)会被PTX选择性地改变,但不会被霍乱毒素(CTX)改变。在本研究中,我们检测了细菌毒素对PC12细胞中蜂毒明肽作用的影响。在没有氯化钙的情况下,蜂毒明肽刺激预先标记的PC12细胞释放[3H]去甲肾上腺素(NA),尽管高钾或ATP以钙依赖的方式刺激释放。用CTX而非PTX预处理24小时可抑制蜂毒明肽刺激的[3H]NA释放。蜂毒明肽以剂量依赖的方式抑制福斯高林刺激的环磷酸腺苷(cAMP)积累,尽管蜂毒明肽本身没有作用。用PTX预处理可完全消除卡巴胆碱通过Gi对cAMP积累的抑制作用,并部分降低蜂毒明肽的作用。然而,20微摩尔蜂毒明肽的抑制作用不会因PTX预处理而改变。因此,我们研究了蜂毒明肽对PC12细胞中CTX催化的蛋白质[32P]ADP核糖基化的影响。CTX的A亚基(CTX-A)催化PC12细胞胞质部分中许多蛋白质的[32P]ADP核糖基化。其中一种是20 kDa的蛋白质,称为ADP核糖基化因子(ARF)。在存在胞质部分的情况下,向测定混合物中添加蜂毒明肽可抑制包括ARF和CTX-A在内的许多蛋白质的ADP核糖基化。然而,在没有胞质部分的情况下,蜂毒明肽会轻微增强牛血清白蛋白的ADP核糖基化以及CTX-A的自身ADP核糖基化。蜂毒明肽不会抑制膜部分中Gs的α亚基的ADP核糖基化。这些发现表明:1)蜂毒明肽与对PTX不敏感且对CTX敏感的因子相互作用以刺激NA释放;2)蜂毒明肽与ARF相互作用抑制其活性,从而增强CTX的ADP核糖基化反应。ARF可能是一种与胞吐作用相关的G蛋白。